Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs: Implications for potential therapy

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2082-2086

  Kedes, Dean H ^a   Ganem, Don ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CBL 1; HHV 8; IC50; KSHV

Indexed keywords

A 77003; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; VIRUS DNA;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DRUG SENSITIVITY; HERPES VIRUS; HUMAN; HUMAN CELL; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LYMPHOMA CELL LINE; PRIORITY JOURNAL; VIRION; VIRUS CAPSID; VIRUS REPLICATION;

EID: 0030980240     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119380     Document Type: Article

References (34)

1. Beral, V. 1991. Epidemiology of Kaposi's sarcoma. In Cancer, HIV and AIDS. Vol. 10. V. Beral, H.W. Jaffe, and R. Weiss, editors. Cold Spring Harbor Press, Cold Spring Harbor, NY. 5-22.
2. Penn, I. 1979. Kaposi's sarcoma in organ transplant recipients. Transplantation (Baltimore). 27:8-11.
3. Ziegler, J., A.C. Templeton, and G.L. Voegel. 1984. KS: a comparison of classical, endemic and epidemic forms. Semin. Oncol. 11:47-52.
4. Franceschi, S., G. Rezza, D. Serraino, A.C. Lepri, M. Geddes, and T. Cote. 1995. Risk for Kaposi's sarcoma among Italian women with AIDS. J. Acquir. Immune Defic. Syndr. 9:313-314.
5. Serraino, D., S. Franceschi, L.D. Maso, and C.L. Vecchia. 1995. HIV transmission and Kaposi's sarcoma among European women. AIDS. 9:971-973.
6. Rabken, C.S., R.J. Biggar, M.S. Baptiste, T. Abe, B.A. Kohler, and P.C. Nasca. 1993. Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int. J. Cancer. 55:208-212.
7. Morlat, P., P. Parneix, D. Douard, D. Lacoste, M. Dupon, G. Chene, J.-L. Pellegrin, J.-M. Ragnaud, F. Dabis, and Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. 1992. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. AIDS. 6:1187-1193.
8. Albrecht, H., E.B. Helm, A. Plettenberg, C. Emminger, W. Heise, B. Schwartlander, and H.-J. Stellbrink. 1994. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature. Genitourin Med. 70:394-398.
9. Doutrelepont, J.M., L.D. Pauw, S.A. Gruber, D.L. Dunn, W. Qunibi, P. Kinnaert, P. Vereerstraeten, I. Penn, and D. Abramowicz. 1996. Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. Transplantation (Baltimore). 62:463-466.
10. Chang, Y., E. Cesarman, M. Pessin, F. Lee, J. Culpepper, D. Knowles, and P. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (Wash. DC). 266:1865-1869.
11. Moore, P., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N. Engl. J. Med. 332:1181-1185.
12. Cesarman, E., Y. Chang, P. Moore, J. Said, and D. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
13. Whitby, D., M. Howard, M. Tenent-FIowers, N. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F. Suggett, D. Aldam, A. Denton, et al. 1995. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 346:799-802.
14. Jones, J.L., D.L. Hanson, S.Y. Chu, J.W. Ward, and W.H. Jaffe. 1995. AIDS-associated Kaposi's sarcoma. Science (Wash. DC). 267:1078-1079.
15. Kedes, D., E. Operskalski, M. Busch, R. Kohn, J. Flood, and D. Ganem. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat. Med. 2:918-924.
16. Gao, S.-J., L. Kingsley, M. Li, W. Zheng, C. Parravicini, J. Ziegler, R. Newton, C.R. Rinaldo, A. Saah, J. Phair, et al. 1996. KSHV antibodies among Americans. Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 2:925-928.
17. Staskus, K.A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D.J. Anderson, D. Ganem, and A.T. Haase. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindie) tumor cells. J. Virol. 71:715-719.
18. Boshoff, C., T. Schulz, M. Kennedy, A. Graham, C. Fisher, A. Thomas, J. McGee, R. Weiss, and J. O'Leary. 1995. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274-1278.
19. Mesri, E.A., E. Cesarman, L. Arvanitakis, S. Rafii, M.A. Moore, D.N. Posnett, D.M. Knowles, and A.S. Asch. 1996. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells, J. Exp. Med. 183:2385-2390.
20. Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346.
21. Hitchcock, M.J.M., H.S. Jaffe, J.C. Martin, and R.J. Stagg. 1996. Cidofovir, a new agent with potent anti-herpesvirus activity. Antivir. Chem. Chemother. 7:115-127.
22. Ho, H.-T., K.L. Woods, J.J. Bronson, H.D. Boeck, J.C. Martin, and M.J.M. Hitchcock. 1992. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41:197-202.
23. Lietman, P.S. 1992. Clinical pharmacology: foscarnet. Am. J. Med. 92: 8S-11S.
24. DeClercq, E. 1996. Therapeutic potential of Cidofovir (HPMPC. Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verhandelingen - Koninklijke Academie voor Geneeskunde Van Belgie. 58:19-47.
25. Hayden, F.G. 1995. Antiviral agents. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Vol. 1. G.L. Mandell, J.E. Bennet, and R. Dolin, editors. J. Wiley and Sons, New York. 411-450.
26. Kempf, D.J., K.C. Marsh, D.A. Paul, M.F. Knigge, D.W. Norbeck, W.E. Kohlbrenner, L. Codacovi, S. Vasavanonda, P. Bryant, X.C. Wang, et al. 1991. Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 35:2209-2214.
27. Nahata, M.C. 1995. Viral infections. In Applied Therapeutics: The Clinical Use of Drugs. L.Y. Young and M.A. Koda-Kimble, editors. Applied Therapeutics, Inc., Vancouver. 70-1-70-13.
28. Foreman, K.J.F., Jr., W. Kong, C. Woffendin, P. Polverini, B. Nickoloff, and G. Nabel. 1997. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N. Engl. J. Med. 336:163-171.
29. Moore, P., S. Gao, G. Dominguez, E. Cesarman, O. Lungu, D. Knowles, R. Garber, P. Pellett, D. McGeoch, and Y. Chang. 1996. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70:549-558.
30. Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi's sarcoma-associated herpesvirus genes in Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA. 93:6641-6646.
31. Moore, P. 1995. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 10:175-180.
32. Glesby, M.J., D.R. Hoover, S. Weng, N.M.H. Graham, J,P. Phair, R. Detels, M. Ho, and A.J. Saah. 1996. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J. Infect. Dis. 173:1477-1480.
33. Costagliola, D., and M. Mary-Krause. 1995. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodeficience Humaine [letter]. Lancet. 346:578.
34. Morfeldt, L., and J. Torssander. 1994. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand. J. Infect. Dis. 26:749-752.